275 related articles for article (PubMed ID: 21763478)
1. Differential roles of CCN family proteins during osteoblast differentiation: Involvement of Smad and MAPK signaling pathways.
Kawaki H; Kubota S; Suzuki A; Suzuki M; Kohsaka K; Hoshi K; Fujii T; Lazar N; Ohgawara T; Maeda T; Perbal B; Takano-Yamamoto T; Takigawa M
Bone; 2011 Nov; 49(5):975-89. PubMed ID: 21763478
[TBL] [Abstract][Full Text] [Related]
2. PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest.
Datta NS; Chen C; Berry JE; McCauley LK
J Bone Miner Res; 2005 Jun; 20(6):1051-64. PubMed ID: 15883646
[TBL] [Abstract][Full Text] [Related]
3. Osthole-mediated cell differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway in human osteoblast cells.
Kuo PL; Hsu YL; Chang CH; Chang JK
J Pharmacol Exp Ther; 2005 Sep; 314(3):1290-9. PubMed ID: 15956019
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
[TBL] [Abstract][Full Text] [Related]
5. Mechanical stress-mediated Runx2 activation is dependent on Ras/ERK1/2 MAPK signaling in osteoblasts.
Kanno T; Takahashi T; Tsujisawa T; Ariyoshi W; Nishihara T
J Cell Biochem; 2007 Aug; 101(5):1266-77. PubMed ID: 17265428
[TBL] [Abstract][Full Text] [Related]
6. Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells.
Xiao G; Gopalakrishnan R; Jiang D; Reith E; Benson MD; Franceschi RT
J Bone Miner Res; 2002 Jan; 17(1):101-10. PubMed ID: 11771655
[TBL] [Abstract][Full Text] [Related]
7. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD
Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945
[TBL] [Abstract][Full Text] [Related]
8. Alphavbeta integrins play an essential role in BMP-2 induction of osteoblast differentiation.
Lai CF; Cheng SL
J Bone Miner Res; 2005 Feb; 20(2):330-40. PubMed ID: 15647827
[TBL] [Abstract][Full Text] [Related]
9. Fidgetin-like 1 gene inhibited by basic fibroblast growth factor regulates the proliferation and differentiation of osteoblasts.
Park SJ; Kim SJ; Rhee Y; Byun JH; Kim SH; Kim MH; Lee EJ; Lim SK
J Bone Miner Res; 2007 Jun; 22(6):889-96. PubMed ID: 17352653
[TBL] [Abstract][Full Text] [Related]
10. Simvastatin promotes osteoblast viability and differentiation via Ras/Smad/Erk/BMP-2 signaling pathway.
Chen PY; Sun JS; Tsuang YH; Chen MH; Weng PW; Lin FH
Nutr Res; 2010 Mar; 30(3):191-9. PubMed ID: 20417880
[TBL] [Abstract][Full Text] [Related]
11. Pro-inflammatory cytokines TNF-related weak inducer of apoptosis (TWEAK) and TNFalpha induce the mitogen-activated protein kinase (MAPK)-dependent expression of sclerostin in human osteoblasts.
Vincent C; Findlay DM; Welldon KJ; Wijenayaka AR; Zheng TS; Haynes DR; Fazzalari NL; Evdokiou A; Atkins GJ
J Bone Miner Res; 2009 Aug; 24(8):1434-49. PubMed ID: 19292615
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of p38 MAPK signaling in chondrocyte cultures results in enhanced osteogenic differentiation of perichondral cells.
Stanton LA; Beier F
Exp Cell Res; 2007 Jan; 313(1):146-55. PubMed ID: 17067574
[TBL] [Abstract][Full Text] [Related]
13. Role of CCN, a vertebrate specific gene family, in development.
Katsube K; Sakamoto K; Tamamura Y; Yamaguchi A
Dev Growth Differ; 2009 Jan; 51(1):55-67. PubMed ID: 19128405
[TBL] [Abstract][Full Text] [Related]
14. Four and half lim protein 2 (FHL2) stimulates osteoblast differentiation.
Lai CF; Bai S; Uthgenannt BA; Halstead LR; McLoughlin P; Schafer BW; Chu PH; Chen J; Otey CA; Cao X; Cheng SL
J Bone Miner Res; 2006 Jan; 21(1):17-28. PubMed ID: 16355270
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor activity is involved in the osteoblastic differentiation regulated by bone morphogenetic proteins and tumor necrosis factor-α.
Takano M; Otsuka F; Matsumoto Y; Inagaki K; Takeda M; Nakamura E; Tsukamoto N; Miyoshi T; Sada KE; Makino H
Mol Cell Endocrinol; 2012 Jan; 348(1):224-32. PubMed ID: 21888945
[TBL] [Abstract][Full Text] [Related]
16. Bone sialoprotein expression enhances osteoblast differentiation and matrix mineralization in vitro.
Gordon JA; Tye CE; Sampaio AV; Underhill TM; Hunter GK; Goldberg HA
Bone; 2007 Sep; 41(3):462-73. PubMed ID: 17572166
[TBL] [Abstract][Full Text] [Related]
17. Expression and regulation of CCN genes in murine osteoblasts.
Parisi MS; Gazzerro E; Rydziel S; Canalis E
Bone; 2006 May; 38(5):671-7. PubMed ID: 16311085
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of CCN-family members in primary human bone marrow-derived mesenchymal stem cells during osteogenic, chondrogenic and adipogenic differentiation.
Schutze N; Noth U; Schneidereit J; Hendrich C; Jakob F
Cell Commun Signal; 2005 Mar; 3(1):5. PubMed ID: 15773998
[TBL] [Abstract][Full Text] [Related]
19. Bone morphogenetic protein 2 induces dental follicle cells to differentiate toward a cementoblast/osteoblast phenotype.
Zhao M; Xiao G; Berry JE; Franceschi RT; Reddi A; Somerman MJ
J Bone Miner Res; 2002 Aug; 17(8):1441-51. PubMed ID: 12162498
[TBL] [Abstract][Full Text] [Related]
20. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
Häusler KD; Horwood NJ; Chuman Y; Fisher JL; Ellis J; Martin TJ; Rubin JS; Gillespie MT
J Bone Miner Res; 2004 Nov; 19(11):1873-81. PubMed ID: 15476588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
